首页> 外国专利> A composition containing zebrafish AKAP?? and a use of AKAP?? mutant zebrafish as a animal model

A composition containing zebrafish AKAP?? and a use of AKAP?? mutant zebrafish as a animal model

机译:含有斑马鱼AKAP的组合物?和AKAP的使用?斑马鱼突变体作为动物模型

摘要

The present invention relates to a composition comprised of AKAP12 (A-Kinase anchoring protein 12) and to uses of AKAP12 mutant zebrafish as an animal model. More particularly, the following characteristics are noted in the present AKAP12 mRNA knockdown zebrafish: crooked or shortened tail, inability to move normally, non-uniform micro-vasculature in the brain, and change in heart shape with non-uniform and weak heartbeats. It also has various circulatory and genetic defects, such as hemorrhage from the ventricles of the heart, brain, and retina. All of these defects can be cured with AKAP12 injection. Therefore, AKAP12 can be used as an active component for a composition to prevent and heal circulatory and genetic defects that are caused by AKAP12 deficiency, and as a hemorrhage inhibitor. Further, the AKAP12 deficient mutant zebrafish can be useful as an animal model for verification of effectiveness of treatment for genetic defects in the circulatory system.
机译:本发明涉及由AKAP12(A-激酶锚定蛋白12)组成的组合物,并涉及AKAP12突变斑马鱼作为动物模型的用途。更具体地,在本发明的AKAP12 mRNA敲低的斑马鱼中注意到以下特征:弯曲或短尾,不能正常移动,大脑中微血管不均匀以及心跳不均匀且心跳弱的形状改变。它还具有各种循环和遗传缺陷,例如心脏,大脑和视网膜心室出血。所有这些缺陷都可以通过AKAP12注射来治愈。因此,AKAP12可用作组合物的活性成分,以预防和治愈由AKAP12缺乏引起的循环和遗传缺陷,并用作出血抑制剂。此外,AKAP12缺陷型突变斑马鱼可用作动物模型,可用于验证循环系统遗传缺陷治疗的有效性。

著录项

  • 公开/公告号KR101133289B1

    专利类型

  • 公开/公告日2012-04-05

    原文格式PDF

  • 申请/专利权人

    申请/专利号KR20080055700

  • 发明设计人 김규원;권혁범;

    申请日2008-06-13

  • 分类号A61K38/16;A61K38;

  • 国家 KR

  • 入库时间 2022-08-21 17:08:19

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号